Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
NCT00153270 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2009-02-19
Summary
The purpose of this study is to determine whether antiepileptic drug sodium valproate is effective in the treatment of chronic asthma.
Conditions
- Bronchial Asthma
Interventions
- DRUG
-
Sodium Valproate
Sponsors & Collaborators
-
Rea Rehabilitation Centre, Georgia
collaborator OTHER -
Centre of Chinese Medicine, Georgia
lead OTHER
Principal Investigators
-
Merab Lomia, MD · "Rea" Rehabilitation Centre
-
Manana Tchaia, MD · Centre of Chinese Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2001-04-30
More Related Trials
-
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT02127697 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma
NCT01195207 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
NCT01316315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 ·Status: COMPLETED ·Phase: PHASE1
-
Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
NCT03137784 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
To Investigate the Prevalence of Children Asthma in China
NCT01319292 ·Status: COMPLETED
-
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
NCT07011524 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
NCT03237221 ·Status: COMPLETED
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
NCT00358488 ·Status: COMPLETED ·Phase: PHASE2
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
NCT01103037 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects
NCT01339897 ·Status: COMPLETED ·Phase: PHASE1
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
NCT02563067 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SA09012 in Asthma
NCT01740986 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-Inflammatory Lipid Mediators in Asthma
NCT03680976 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.
NCT06514157 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China
NCT02965807 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of MK0359 in Patients With Chronic Asthma (0359-013)
NCT00482898 ·Status: COMPLETED ·Phase: PHASE2
-
SMART@Home Feasibility Trial
NCT06159127 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of CRD007 in Adult Asthma Subjects
NCT02615080 ·Status: COMPLETED ·Phase: PHASE2